CAPITOL COUNSEL LLC for LUNDBECK PHARMACEUTICALS LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY CARROLL | — |
| JOSEPH EANNELLO | — |
| SHANNON FINLEY | — |
| LUKE HATZIS | — |
| ANN JABLON | — |
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
| KAREN STONE | — |
Medicare/Medicaid MMM
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY CARROLL | — |
| JOSEPH EANNELLO | — |
| SHANNON FINLEY | — |
| LUKE HATZIS | — |
| ANN JABLON | — |
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
| KAREN STONE | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.